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Abstract
An association between enrichment and depletion of microRNA (miRNA) binding sites, 39 UTR length, and mRNA expression
has been demonstrated in various developing tissues and tissues from different mature organs; but functional, context-
dependent miRNA regulations have yet to be elucidated. Towards that goal, we examined miRNA–mRNA interactions by
measuring miRNA and mRNA in the same tissue during development and also in malignant conditions. We identified
significant miRNA-mediated biological process categories in developing mouse cerebellum and lung using non-targeted
mRNA expression as the negative control. Although miRNAs in general suppress target mRNA messages, many predicted
miRNA targets demonstrate a significantly higher level of co-expression than non-target genes in developing cerebellum.
This phenomenon is tissue specific since it is not observed in developing lungs. Comparison of mouse cerebellar
development and medulloblastoma demonstrates a shared miRNA–mRNA co-expression program for brain-specific
neurologic processes such as synaptic transmission and exocytosis, in which miRNA target expression increases with the
accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these miRNAs in brain tumors.
These findings demonstrate the context-dependence of miRNA–mRNA co-expression.
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Introduction
MicroRNAs (miRNA) are short (,22 nt), single-stranded non-
coding RNAs that regulate mRNA gene expression at multiple
levels [1–6]. The importance of these micro-regulators is
evidenced by the increasing number of miRNAs that have been
identified; up to 1/3 of human genes are estimated to be miRNA
targets. Detailed studies of the expression of both individual
miRNAs [7–14] and large sets of miRNAs [2,15–16] indicate that,
in general, miRNAs suppress mRNA messages. In studies of the
expression of large miRNA sets, enrichment or depletion of
miRNA binding sites and 39 UTR length have been evaluated
with respect to gene expression in various tissues and during
development. Farh et al. reported miRNA-induced repression of
mRNA in myoblast differentiation and tissue-specific signatures
based on comparisons of conserved and non-conserved sites [2].
Stark et al. reported depletion of miRNA binding sites on genes
involved in basic cellular processes [16]. For several miRNAs, co-
expressed genes avoid miRNA binding sites while target genes and
miRNAs are preferentially expressed in neighboring tissues during
Drosophila embryonic development. Both Stark et al. and Sood et
al. reported a bias of a longer 39 UTR length and more miRNA
binding sites in genes involved in neurogenesis and in genes highly
expressed in neuronal tissues [15–16].
Although there are tissue-specific signatures of miRNA
repression or miRNA–mRNA mutual-exclusiveness for several
highly expressed miRNAs, the pattern of miRNA target gene
expression is complicated, especially in the central nervous system
(CNS) [2,15–16]. We examined miRNA–mRNA interactions by
studying large numbers of miRNAs and the expression of their
predicted mRNA targets during the same developmental stages in
mouse cerebellum as studied in previous reports for the following
reasons. First, we wished to capture more than the dependencies/
effects of highly expressed miRNAs. Second, the results of
biochemical studies indicate that miRNA repression of mRNA is
dependent on the specific cellular conditions [17], hence both
tissue-specific and temporal-specific studies are needed to define
each condition. Third, the extensive transcriptional program of
development is well suited for identifying dynamic miRNA/
mRNA interactions in vivo.
To understand the functional roles of miRNAs during
development, we assigned their respective target genes to
ontological groups based on Gene Ontology (GO), as described
in Sood et al.[15]. For consistency, in this manuscript we used
the term ‘‘target’’ for any predicted mRNA gene of some known
miRNA, accordingly ‘‘non-target’’ is used for the complement of
predicted targets. For each miRNA, we identified the statistically
significant GO terms among the miRNA’s computationally
predicted mRNA ‘‘target set’’ that were differentiated from the
non-target genes that had positive-correlated developmental
profile to the target set. This comparison with non-target genes
was performed because the use of non-target genes as a negative
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5436control might allow for better recognition of miRNA-mediated
features and minimizes the influence of cell type. We defined a
developmentally coherent target [coherent target] of a
miRNA as a predicted target whose expression negatively
correlated with the miRNA. The assumption here is that
miRNAs primarily act as suppressors of mRNA during
development. Accordingly, a developmentally non-coherent
target [non-coherent target] was defined as one whose gene
expression was not altered in response to the suppressive function
of the miRNA in developing cerebellum. This notion of a non-
coherent target is unrelated to Stark’s notion of a depletion of
miRNA binding sites on mRNA that are co-expressed in a given
tissue with an miRNA. Non-coherent targets may co-express with
miRNAs despite their 39UTRs being enriched for the binding
sites of those miRNAs.
The conservation of mechanisms across development and
tumorigenesis and the significant roles of miRNA in both
development and tumorigenesis [10,11,18–22] also motivated
our investigation of miRNA–mRNA interactions in both
tumors and their cognate developing tissue. Therefore, we
intersected the coherent and non-coherent target gene sets
observed during cerebellar development with the up- or
down-regulated gene sets observed in Ptch+/2 medulloblas-
toma (MB) and compared the logarithmic fold change of
expression in tumor with that of the up- or down-regulated
non-target genes. As a tissue-specificity control, functional
gene sets in murine lung development and lung cancers were
studied in parallel. The design of this tissue-specific and
temporal-specific functional study of miRNA–mRNA target
interaction across development and tumorigenesis is illustrated
in Figure 1.
Results
The number of miRNA non-coherent targets is equivalent
to that of miRNA coherent targets in developing
cerebellum and lung tissue
We focused on postnatal days 7 (P7) and P60 for cerebellar
development, because the highest level of granule neuron
precursor proliferation and migration occurs during P7 and the
development of mouse Ptch+/2 MB is most closely associated
with stage P7 [20], whereas P60 is an adult stage during which
miRNA levels are assumed to be stable. Using customized RAKE
miRNA microchips [23], we profiled wild-type mouse miRNA
expression in developing cerebellum at postnatal stages P7 and
P60 (Table 1 and Figure S1). In parallel, we studied the miRNA
expression in developing lung at stages P1 and P14, as described in
Williams et al. [24]. We have previously reported on total RNA
expression in developing mouse cerebellum for P1, P3, P5, P7,
P10, P15, P21, P30, P50, and P60 based on the Affymetrix
Mu11K arrays [25]. A complete time series of mRNA expression,
(also Mu11K arrays), of perfused whole wild-type mouse lung for
embryonic days 12, 14, 16, and 18, and postnatal days P1, P4, P7,
P10, P14, and P21, covering the five main stages of mouse lung
development [26] was also available [27].
TargetScanS [28] computational prediction of targets for 54
conserved miRNAs in developing cerebellum and 59 miRNAs in
developing lung was performed. For each miRNA, we identified
the coherent target and non-coherent target sets using the P7 and
P60 data points in developing cerebellum and likewise we did the
test using the P1 and P14 data points in developing lung. Positive
correlation between miRNA and mRNA target is considered
non-coherent and accordingly negative correlation is considered
Figure 1. Design flow of the functional tissue-specific study of miRNA–mRNA interactions in development and malignancy.
doi:10.1371/journal.pone.0005436.g001
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miRNA Name
pval (Day 7B
vs Day 60C)
ranked data
Data
P7
Data
P60 Log2 FC
Num of
coherent gns
(Seri. A) using
TargetScanS
Num of Non-
coherent gns
(Seri. A) using
TargetScanS
Num of
coherent
gns (Seri.
A) using
PITA
Num of
Non-coherent
gns (Seri. A)
using PITA
Num of
coherent
gns (Seri.
A) using
picTar
Num of
Non-
coherent
gns (Seri.
A) using
picTar
mmu-let-7a 0.89827 65423 65481 0.0012784 110 99 97 87 109 95
mmu-mir-124a 0.0021645 22091 65482 1.5676397 274 249 201 165 163 127
mmu-mir-125a 0.064935 8299 56964 2.779041 87 85 141 132 88 78
mmu-mir-103-1,2 0.39394 4940 15020 1.6043019 68 84 77 80 113 154
mmu-mir-9 0.004329 1354 3855 1.5095031 162 177 153 125 139 157
mmu-mir-23b 0.0021645 1262 5891 2.2228006 123 126 161 131 78 82
mmu-mir-206 0.0021645 1083 3019 1.4790375 121 116 93 90 111 104
mmu-mir-15 0.0021645 680 1402 1.0438797 122 151 164 191 120 152
mmu-mir-30b 0.0021645 590 21826 5.209189 191 162 188 164 122 100
mmu-mir-99b 0.015152 450 5933 3.7207649 6 6 7 7 5 5
mmu-mir-221 0.0021645 426 3083 2.8554096 60 43 61 69 50 49
mmu-mir-187 0.39394 399 1002 1.3284219 0 2 11 11 0 3
mmu-mir-138 0.0021645 372 854 1.1989334 58 60 71 66 56 50
mmu-mir-194 0.0021645 309 4231 3.7753199 55 48 52 54 37 41
mmu-mir-133 0.0021645 287 1585 2.4653602 72 69 67 62 66 68
mmu-mir-21 0.0021645 275 1555 2.4994111 34 29 59 47 37 26
mmu-mir-204 0.0021645 266 4643 4.1255591 70 63 86 91 71 63
mmu-mir-34a 0.0021645 155 1873 3.5950108 86 75 86 85 81 77
mmu-mir-152 0.0021645 102 313 1.6175935 74 102 109 117 65 92
mmu-mir-218-1,2 0.0021645 93 2281 4.6162919 79 111 111 113 77 100
mmu-mir-182 0.0021645 86 424 2.3016557 114 115 119 99 130 134
mmu-mir-146 0.0021645 85 238 1.4854268 29 22 39 32 23 22
mmu-mir-7 0.0021645 38 214 2.4935395 54 54 57 55 53 55
mmu-mir-101 0.0021645 34 70 1.0418202 53 55 89 90 94 104
mmu-mir-139 0.0021645 33 51 0.6280312 58 54 78 104 54 49
mmu-mir-223 0.0021645 32 98 1.6147098 45 34 42 51 35 33
mmu-mir-137 0.0021645 24 34 0.5025003 85 80 105 121 72 67
mmu-mir-96 0.0021645 23 50 1.1202942 64 55 87 70 133 138
mmu-mir-128 0.0021645 7840 53416 2.7683464 98 96 140 126 114 120
mmu-mir-26a 0.0021645 4037 65474 4.0195666 134 89 113 81 101 69
mmu-mir-22 0.0021645 1411 11129 2.9795341 60 68 74 72 64 65
mmu-mir-145 0.0021645 730 2578 1.8202839 93 65 87 86 51 41
mmu-mir-143 0.0021645 217 1033 2.2510733 51 40 65 38 45 38
mmu-mir-27b 0.0021645 125 907 2.8591745 103 100 152 157 136 144
mmu-mir-192 0.0021645 86 579 2.7511548 18 19 18 27 21 17
mmu-mir-140 0.0021645 39 41 0.0721498 38 33 61 57 42 42
mmu-mir-216 0.0021645 1135 24 25.5635141 27 23 68 68 23 20
mmu-mir-375 0.1 36 8 22.169925 42 45 7 10 24 27
mmu-mir-144 0.93723 24 9 21.4150375 21 21 112 122 98 108
mmu-mir-181a 0.0021645 32848 27769 20.2423303 125 130 137 168 86 93
mmu-mir-93 0.0021645 15075 1561 23.2716156 72 71 159 151 136 129
mmu-mir-130 0.0021645 12033 3819 21.6557295 99 73 135 103 120 87
mmu-mir-92-1,2 0.0021645 11935 364 25.0351163 128 102 97 86 92 62
mmu-mir-106 0.0021645 3563 234 23.928512 156 120 159 146 135 107
mmu-mir-217 0.0021645 450 18 24.6438562 28 44 69 74 31 37
mmu-mir-122a 0.0021645 270 49 22.4621058 33 27 26 30 30 25
miRNA–mRNA Co-Expression
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non-coherent targets was equivalent to that of coherent targets for
each miRNA, regardless of its level of expression (Table 1 and
Table S1). The mean number of coherent targets per miRNA was
76 in developing cerebellum and 66 in developing lung, and the
number of non-coherent targets was 72 and 69, respectively.
We performed the same procedure using PITA[29] and
picTar[30] target predictions and found similar phenomenon in
each case, (the right two columns of Table 1 and Table S1).
Likewise, in the following findings we conducted the tests with
PITA and picTar predictions as well in addition to TargetScans in
order to exclude algorithm-specific artifact. Results of the
comparisons are demonstrated in each place where such a purpose
is addressed.
miRNAs can be classified according to the coherence and
non-coherence of their target sets in developing
cerebellum
We next examined whether miRNAs can be classified according
to the coherence and non-coherence of their targets during
development given that we found non-coherent targets to be as
common as coherent ones. Using non-target genes as a negative
control, we compared the changes in mRNA expression of
coherent targets or non-coherent targets for each miRNA with
those of changes in the expression of non-target genes that had a
positively correlated developmental profile to the target set in test.
We then computed the statistic of the tests to identify which
miRNAs are significant when their coherent targets are compared
with the non-target control set and which are significant when
tested for their non-coherent targets. In conjunction with the two
types of miRNAs (developmentally early expressed/early-ex-
pressed miRNAs and developmentally late expressed/late-ex-
pressed miRNAs), there shall be four types of test in all. The tests
revealed two significant (Wilcoxon ranksum test p,0.05) miRNA
expression patterns during development as demonstrated in
Figure 2. The average logarithmic relative expression of miRNA
targets at day P60 compared to that of P7 was plotted against that
of the corresponding background non-target genes. We use
‘‘LNCoh’’ to denote late-expressed miRNAs significant for their
non-coherent targets (Figure 2A shows for the miRNAs, Figure 2B
for the corresponding mRNA non-coherent targets), and ‘‘ECoh’’
to denote early-expressed miRNAs significant for their coherent
targets (Figure 2C for the miRs, Figure 2D for the corresponding
mRNA coherent targets).
The graphs in Figure 2 illustrate the opposite effects of the
miRNAs on the coherent and non-coherent genes. In the
developing cerebellum, 12 of the 36 late-expressed miRNAs were
LNCoh and 7 of the 18 early-expressed miRNAs were ECoh
(Table 2). Using the prediction by PITA and picTar, we identified
a similar set of significant miRNAs. In the case of using PITA
prediction, 22 of 36 late-expressed miRNAs were LNCoh-type
while 10 of the 18 early-expressed miRNAs wer ECoh-type (Table
S2). With picTar prediction, 13 of the late miRNAs were LNCoh-
type and 9 of the 18 early miRNAs were ECoh-type (Table S3).
Both non-coherent targets for early expressed miRNAs and
coherent targets for late expressed miRNAs are not statistically
significant compared with the corresponding non-target back-
ground gene set. It is noteworthy that as the miRNA expression
decreases, the upregulation of coherent targets of the ECoh-type
miRNAs is significantly greater than that of the non-target genes
and, more surprisingly, the non-coherent targets of the LNCoh-
type miRNAs escape even further from miRNA suppression than
non-target genes.
Interestingly, both miR-124 (a highly brain-specific miRNA)
and miR-9 (a highly functional miRNA in brain development) are
expressed late in development and are significant when their non-
coherent targets are compared with the non-target control gene
set. In comparison, there are far fewer significant miRNAs either
for the non-coherence or for the coherence of their targets in the
developing lung, where there is no apparent bias towards a
particular category (Table S4). These results suggest that many
late-expressed miRNAs mediate target non-coherence in a tissue-
specific and functional manner.
Non-coherent target sets of late-expressed miRNAs
correspond significantly with processes involving cell-
communication among which synaptic transmission and
others co-express multiple miRNAs at a significantly
higher level than do non-targets
Based on the finding that late miRNAs are characterized by the
non-coherence of their targets, we examined the ontological
correlates of the target sets. Among the non-coherent targets of the
miRNA Name
pval (Day 7B
vs Day 60C)
ranked data
Data
P7
Data
P60 Log2 FC
Num of
coherent gns
(Seri. A) using
TargetScanS
Num of Non-
coherent gns
(Seri. A) using
TargetScanS
Num of
coherent
gns (Seri.
A) using
PITA
Num of
Non-coherent
gns (Seri. A)
using PITA
Num of
coherent
gns (Seri.
A) using
picTar
Num of
Non-
coherent
gns (Seri.
A) using
picTar
mmu-mir-155 0.0021645 214 54 21.9865795 37 59 56 64 33 47
mmu-mir-184 0.041126 88 64 20.4594316 5 5 6 6 5 5
mmu-mir-199a-1 0.17965 86 7 23.6189098 56 54 128 143 36 51
mmu-mir-19a 0.0021645 56 10 22.4854268 125 124 154 142 131 120
mmu-mir-33 0.39394 45 23 20.9682911 52 34 57 55 43 33
mmu-mir-142-s 0.13203 44 8 22.4594316 40 37 41 58 40 33
mmu-mir-219 0.24026 40 23 20.7983661 43 45 36 31 34 38
mmu-mir-153 0.17965 29 19 20.6100535 75 81 68 89 72 74
pval — the Wilcoxon ranksum test result comparing P7 and P60 ranked sorted miRNA expression;
Log2FC — the logarithmic fold change between P60 and P7 miRNA expression.
doi:10.1371/journal.pone.0005436.t001
Table 1. Cont.
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transducer activity, cell differentiation, and morphogenesis were enriched
with the non-target background as control. Table 3 summarizes
the enriched GO terms of miRNA coherent/non-coherent targets
in developing cerebellum. We further investigated whether the
non-coherent targets associated with these terms were still
significantly enriched against the non-targets associated with the
same terms that positively correlate with the non-coherent targets
and found cell-communication and cell differentiation were again
significant (Table S5). The test statistic is the logarithmic fold-
change of the expression in developing cerebellum as in previous
tests. This finding is important in that although the miRNA
binding sites for mRNA genes of these GO terms are enriched on
a genome scale [16], these functional processes are non-coherent
to miRNA suppression.
To determine the extent to which the non-coherent targets for
each miRNA in terms of GO terms differ from the non-target
genes in developing cerebellum, we investigated the average
logarithmic fold-change of mRNA expression from P7 to P60 and
compared the result with the value of the corresponding non-
target genes that had a positive-correlated developmental profile to
the target set. Many enriched GO terms were co-expressed with
the late-expressed miRNAs at significantly higher levels than that
of non-target genes, with an average fold-change difference of
55%.
We sorted the above obtained GO terms based on their non-
coherent targets’ offset from non-target background genes in terms
of logarithmic fold-change from P7 to P60, their statistical
significance in the enrichment test, and their multiplicity of
miRNAs, respectively (Table 3). Among the non-coherent
ontological gene sets, the terms Metal ion-binding site:Calcium and
Synaptic transmission ranked at the top if the three ranks were
weighted equally. Having the most number of putative binding
miRNAs, Synaptic transmission exhibited a 140% greater fold-change
from P7 to P60 compared with the average non-target late-
expressed genes (p,0.009). A total of 11 miRNAs, let-7, miR-9,
miR-206, miR-138, miR-133, miR-152, miR-137, miR-128, miR-
143, miR-27b and miR-218 were co-expressed by 18 synaptic
transmission target genes (Table S6).
In order to understand the robustness of the non-coherence of
the afore identified pathways in the dynamics of cerebellum
development, we computed the differential expression of target
genes in the intermediate time points (P10, P15, P21, P30) relative
to P7 respectively, versus the miRNA differential expression at P60
relative to P7. A similar list of pathways were found to be
significant in developing cerebellum at these 4 stages (Table S7).
Moreover, the statistical significances at later stages P21 and P30
are higher than at early stages P10 and P15, which demonstrate
progressive nature of developmental non-coherence of mRNA
target of late miRNAs.
Figure 2. Significant opposite effects of the miRNAs on the coherent and non-coherent target genes in developing cerebellum. (A)
Late expressed miRNAs in Table 2. (B) Non-coherent mRNA targets of late expressed miRNAs. (C) Early expressed miRNAs in Table 2. (D) Coherent
mRNA targets of early expressed miRNAs. Dashed line represents average of the non-target genes that expressed late in developing cerebellum.
doi:10.1371/journal.pone.0005436.g002
miRNA–mRNA Co-Expression
PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5436Synaptic transmission is the essential process of transferring
signals between neurons in the CNS [31]. Functioning mainly in
chemical synapses, the 18 synaptic transmission genes cover the
different stages of both presynaptic and postsynaptic neurotrans-
mission at the synapse. For example, SYT1 and SNAP-25 are
presynaptic proteins involved in neurotransmitter release, whereas
GABARAPL1 is a postsynaptic receptor. Some synaptic trans-
mission genes, such as RIT2, are exclusively expressed in neurons.
We examined whether there is a hierarchical relationship among
the enriched GO terms and their relation, if any, to synaptic
transmission. We identified two pedigree sub-trees of GO terms that
were closely related in the context of the synapse: a cell
communication-rooted tree branching to synaptic transmission and a
localization-rooted tree branching to exocytosis, which is the process
that releases neurotransmitters into the synaptic cleft.
We further investigated whether the non-coherent target set of
synaptic transmission was significant using the non-target synaptic
transmission genes as controls because on average, late-expressed
synaptic transmission non-target genes have a higher fold-change
from P7 to P60 than do other non-target genes. Again, the non-
coherent synaptic transmission genes were significant in this case for
each miRNA involved (p,0.05). Moreover, the processes in the
two sub-trees of GO terms (mentioned above) are generally among
the most significant. Comparison of the non-coherent exocytosis
targets with the non-target exocytosis genes revealed a similar
phenomenon. This finding suggests the enriched non-coherent
GO processes are not isolated events, but rather functionally
consistent phenomena mediated by miRNA.
We performed the same statistical test and analysis for the
enrichment of non-coherent GO processes using the targets
predicted by PITA and picTar. Comparing the results (Table S8,
S9) with the findings using TargetScanS prediction, we found that
Synaptic transmission again ranked at the top and the related GO
processes are included in the list of significant terms. The coherent
ontological gene sets are also tested (Table S8, S9) and we found
discrepancy in results using different predictors. In particular, the
most enriched coherent terms from TargetScanS include basic
processes such as Physiological process, cellular process, DNA
metabolism and chromatin assembly/disassembly that are not
largely represented in PITA and picTar target predictions and
thus are not identified as significant ones using the other two
predictors.
A common miRNA–mRNA co-expression program of
non-coherent target sets of GO processes is shared
between developing cerebellum and medulloblastoma
(MB): example of two sub-trees of GO terms
The functional enrichment of groups of non-coherent ontolog-
ical target sets reveals a positive output of targets toward the
Table 2. Significant miRNAs in mouse cerebellum development.
Significant miRNAs in cerebellum dev. for their non-coherent targets
miRNA Name Dev Status
Num and % of
non-coherent genes
Log2 (P60/P7)
of the miR Ave. Log FC offset P-val (a) P-val (b)
hsa-mir-15 Late 151/55.31% 1.044 0.029 0.0001 7.03E-05
mmu-mir-124a Late 249/47.61% 1.568 0.018 0.0017 0.0010
mmu-mir-152 Late 102/57.95% 1.618 0.031 0.0020 0.0005
hsa-mir-9 Late 177/52.21 1.510 0.022 0.0020 0.0002
mmu-mir-30b Late 162/45.89% 5.209 0.019 0.0028 0.0099
hsa-mir-103-1,2 Late 84/55.26% 1.604 0.031 0.0030 0.0002
hsa-mir-139 Late 54/48.21% 0.628 0.039 0.0045 0.0004
mmu-mir-146 Late 22/43.14% 1.485 0.096 0.0063 0.0465
mmu-mir-206 Late 116/48.95% 1.479 0.035 0.0121 0.0015
mmu-mir-138 Late 60/50.85% 1.199 0.036 0.0174 0.0108
mmu-mir-128 Late 96/49.48% 2.768 0.024 0.0218 0.0161
mmu-mir-204 Late 63/47.37% 4.126 0.017 0.0296 0.0211
Significant miRNAs in cerebellum dev. for their coherent targets
miRNA Name
Dev
Status
Num and % of
coherent genes
Log2 (P60/P7)
of the miR Ave. Log FC offset P-val (a) P-val (b)
hsa-mir-19a Early 125/50.20% 22.485 0.031 1.5023E-05 2.19E-06
hsa-mir-106 Early 156/56.52% 23.929 0.030 2.3594E-05 3.10E-07
hsa-mir-181a Early 125/49.02% 20.242 0.029 0.0001 3.42E-06
miR-93 Early 72/50.35% 23.272 0.030 0.0019 1.78E-05
mmu-mir-153 Early 75/48.08% 20.610 0.036 0.0108 0.0088
hsa-mir-92-1,2 Early 128/55.65% 25.035 0.024 0.0109 0.0001
miR-130 Early 99/57.56% 21.656 0.018 0.0111 0.0181
Ave. LogFC Val offset — average offset of the logarithmic fold change (P60/P7 in dev.) calculated for the involved miRNA non-coherent/coherent targets from that of
non-miRNA target genes;
P-val (a) —the p-vals calculated for the involved miRNA using the logFC of non-coherent targets/coherent targets vs. non-miRNA-target gene background;
P-val (b) (the p-vals calculated from duplicate dev data).
doi:10.1371/journal.pone.0005436.t002
miRNA–mRNA Co-Expression
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5436corresponding miRNAs in developing cerebellum. We examined
whether mRNA targets avoid miRNA suppression in malignant
brain tumors. We identified the intersecting sets of coherent/non-
coherent targets in developing cerebellum and the up/down
targets in mouse Ptch+/2 MB and tested them against the up/
down non-target background genes for enriched GO terms (Table
S10). All significant non-coherent ontological target sets for late
miRNAs were downregulated and all significant coherent
ontological target sets for late miRNAs were upregulated in MB.
As in developing cerebellum, the groups of non-coherent GO
processes for late-expressed miRNAs, including synaptic transmission,
were significantly different from non-target downregulated mRNA
in MB (Table 4). Again, the GO processes were composed of two
sub-trees (Figure 3B), as in development, for shared miRNAs, such
as miR-9, miR-206, miR-138, miR-133, miR-152, and miR-128.
Given that Ptch+/2 MB is most closely associated with stage P7
[20] in developing cerebellum, we compared the adult normal
samples to the Ptch+/2 MB and plotted the average logarithmic
fold-change of mRNA expression of adult normal tissue over
Ptch+/2 MB. Figure 3C shows the cell communication-rooted
sub-tree branching to the synaptic transmission logarithmic fold-
change in both developing tissue and tumor, and Figure 3D shows
the fold-change profiles of the localization-rooted sub-tree
branching to exocytosis. In both figures, the corresponding non-
target genes were used as controls. Interestingly, not only the two
sub-trees of GO terms were shared, the magnitudes and orders of
the terms in MB and developing cerebellum were similar. As
before, we tested the non-coherent synaptic transmission target sets
against non-target down-regulated synaptic transmission genes in MB
and found the non-coherent miRNA targets were still significant,
as were the other GO terms in the two shared sub-trees. The two
sub-trees of GO processes are also shared between developing
cerebellum and Ptch+/2 MB when picTar and PITA predictions
are used (Table S11, S12). For synaptic transmission, miR-128,
miR-27b, miR-133, miR-206, miR-152 and miR-9 are shared
between development and tumor using picTar prediction; miR-
128, miR-140, miR-27b, miR-22, miR-133, miR-223 and miR-
152 are shared using PITA prediction.
We then examined the miRNA expression in brain cancers. We
obtained CNS cancer cell line miRNAs from the NCI-60 database
[32], which were histologically glioblastoma. Glioblastoma is a
primary CNS tumor that sometimes occurs in the cerebellum.
Compared with normal P60 cerebellum, almost all the late
miRNAs in developing cerebellum were downregulated in these
CNS tumor cell lines (Figure 3A). All except one of the involved
miRNAs for the shared two sub-trees of GO terms were
downregulated, and the expression of that one was not changed
(Table S13).
In addition, we tested the human MB cell line and found similar
sharing of significant non-coherent ontological target sets,
including synaptic transmission and exocytosis, between MB and
developing cerebellum (Table S10). Tests in developing lung and
lung cancers performed in parallel revealed that no significant
non-coherent ontological gene sets were shared between them.
Together, these findings indicate that there is common pro-
gram of process-specific miRNA–mRNA co-expression between
Table 4. The statistic significance and other quantifications of the shared miRNA non-coherent GO terms shared between brain
tumor and cerebellum development.
GO terms
p-val
in Dev.
LogFC
Val offset
in Dev.
# of
miRs
in Dev.
p-val
in MB
LogFC
Val offset
in MB
# of
miRs
in MB
# of
common
genes
significant miRNAs shared btw Ptch+/2 MB and
development
‘transmission of nerve
impulse’
0.0046 0.1596 11 0.0043 20.1944 8 18 mir-
128
mir-
218
mir-
133
mir-
206
mir-
152
mir-9 mir-
138
‘synaptic transmission’ 0.0046 0.1596 11 0.0043 20.1944 8 18 mir-
128
mir-
218
mir-
133
mir-
206
mir-
152
mir-9 mir-
138
‘cell communication’ 0.0000 0.0759 1 0.0029 20.0945 4 19 mir-
138
‘transport’ 0.0028 0.0852 8 0.0008 20.1051 5 21 mir-
128
mir-
218
mir-
138
‘cell–cell signaling’ 0.0039 0.1265 6 0.0015 20.1964 4 8 mir-
128
mir-
133
‘localization’ 0.0017 0.0749 8 0.0004 20.1046 4 30 mir-
128
mir-
218
‘establishment of
localization’
0.0017 0.0749 8 0.0004 20.1046 4 30 mir-
128
mir-
218
‘secretion’ 0.0080 0.1748 3 0.0081 20.1637 2 6 mir-
103
mir-
128
‘exocytosis’ 0.0018 0.2142 1 0.0010 20.2354 1 4 mir-
128
‘vesicle-mediated
transport’
0.0054 0.1456 2 0.0091 20.1637 2 7 mir-
103
mir-
128
‘secretory pathway’ 0.0095 0.1825 2 0.0010 20.2354 1 4 mir-
128
p-val — median of the p-vals calculated for the involved miRNAs using the logFC of non-coherent targets targets vs. non-miRNA-target gene background;
LogFC Val offset — offset of the median of the logarithmic fold change (P60/P7 in dev.) calculated for the involved miRNAs non-coherent targets from that of non-
miRNA target genes;
# of miRNAs — number of associated miRNA incidences (common for two duplicates) with the GO terms;
# of common genes — number of common miRNA non-coherent targets shared by developing cerebellum tissue and MB tumor for the associated term.
doi:10.1371/journal.pone.0005436.t004
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5436developing cerebellum and CNS tumors. In particular, the brain-
specific neurologic process synaptic transmission, and two closely
related processes, vesicle-mediated transport and exocytosis, significantly
avoid regulation by the gain of function of multiple miRNAs in
developing cerebellum as well as by the same miRNA’s loss of
function in brain tumors.
miRNA–mRNA co-expression in brain development and
malignancy are tissue-specific
In addition to the fact that fewer miRNAs were found
significant for their target’s coherence or non-coherence in
developing lung than in developing cerebellum (Table S4), there
were also very few common significant GO terms in each of the
types defined as either early or late and coherent or non-coherent
(Table S14).
Between developing cerebellum and lung, only two generic GO
terms are common including cellular physiological process and binding
(Table S14), while overall there were 164 significant non-coherent
ontological gene sets in the cerebellum. Both these two categories
are significantly non-coherent to miR-15. Although synaptic
transmission target set was also significantly non-coherent in
developing lung, it involved only miR-140 and miR-200b, which
Figure 3. Common miRNA–mRNA co-expression pattern. Shared non-coherent ontological gene sets between brain development and tumors
(A) average miRNA profiles in developing cerebellum and tumor, (B) legend and the two sub-tree hierarchy of the synaptic transmission-related
processes. (C,D) developmental mRNA profiles of the brain-specific neurologic terms that significantly avoid miRNA suppression. * Synaptic
transmission and Transmission of nerve impulse share the same set of mRNA target genes; Establishment of localization and Localization share the same
set of mRNA target genes.
doi:10.1371/journal.pone.0005436.g003
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PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5436were different miRNAs from those in developing cerebellum. In
developing lung, no group of GO terms was significantly
associated with synaptic transmission, in contrast to developing
cerebellum. Regulation of the actin cytoskeleton and MAPK signaling
pathway are among the identified lung development-specific non-
coherent ontological target sets for miR-140, which is significant in
lung development for its target non-coherence (Table S4).
Far fewer significant miRNAs were found in developing lung
than in developing cerebellum with picTar and PITA predictions
(Table S15). There is one significant miRNA for its non-coherent
targets (miR-146) and one for coherent targets (miR-204) in the
case of picTar while there are no significant miRNAs when PITA
is used. Comparing the enrichment of GO processes between
developing lung and cerebellum, we found Metal ion transport and
MAPKKK cascade are commonly significantly non-coherent to miR-
15 and that Phosphorylation is commonly significantly coherent to
miR-181 using picTar prediction (Table S16). There are no
significant commonly enriched GO processes found when PITA
prediction is used.
Unlike the shared program described between developing
cerebellum and MB, only three terms such as activator, DNA
binding, and DNA metabolism, were shared between small cell lung
cancer upregulated genes and coherent targets in developing lung,
involving miR-30, miR-200a, and miR-9, respectively. We did not
find any shared processes between small cell lung cancer
upregulated genes and coherent targets in developing lung using
picTar or PITA prediction.
Discussion
This study focused on co-expressed miRNA-target pairs in
temporally-specific and tissue-specific mammalian CNS develop-
ment and malignancy. Many of the late-expressed miRNAs in
developing cerebellum were characterized by their target non-
coherence. Further identification of the shared CNS-specific
network of enriched co-expressed GO terms surrounding synaptic
transmission between cerebellar development and brain tumors
confirmed the tissue and process specific mRNA co-expression
with multiple miRNAs.
It is difficult to explain these findings based only on the mutual
exclusion of miRNAs and targets. Although cell-type variety may
facilitate the mutual exclusion, here the miRNA targets were
compared with non-target genes that had a positively-correlated
developmental profile to the target set using the same assay with
the same averaging of cell-types, thus minimizing the effects of
cell-type. In addition, the limited number of cell types in the
cerebellum and the prevalence of some of the significant
miRNAs in the CNS [33] make it more difficult to apply the
mutual exclusion model. Furthermore, the identified synaptic
transmission process is hard to explain as specific to a particular
neuron.
Transcription factors and miRNA interactions might contribute
to the phenomenon of miRNA–mRNA co-expression. Feedback
loops between these two types of transcription regulators have
been extensively reported [1,12,34–37]. A recent computational
model by Shalgi et al. suggests that in a significant fraction of such
interactions transcription factors regulate the miRNA or are
regulated by miRNA and these forms of feed-forward loops are
often observed in developmental processes. Consistent with the
abundant sites in neuronal tissues of highly expressed genes [15],
Tsang et al. reported co-expression of miRNA-target pairs in
neuronal tissue computed by a score based on the number of
conserved binding sites [38]. Among the two promoter-miRNA-
target interaction models described by Tsang et al.[38], a circuit
named Type I, which is equivalent to the special case of a feed-
forward loop described by Shalgi et al.[36], recurs in different
tissues and might explain the co-expression. Among the brain-
enriched miRNAs, however, only miR-7 and miR-103 are
consistently reported to be involved in the Type I circuit. For
brain tissues, miR-9 and miR-128b are Type I, although miR-
128b is not found in the motor neuron data [38]. As miR-9 is
reported to have a matched binding motif with neuronal repressor
NRSF/REST [39], NRSF might be a promoter that acts in the
Type I circuit. Interestingly, recent findings of the in vivo binding
partners of NRSF show synaptic transmission and other closely
related GO terms among the most significant [40]. When
compared with the 18 synaptic transmission genes evaluated in
this study, however, only 5 genes (GAD1, CACNA1E, NPTX1,
DLG4, and GAD2) are among those on the NRSF list. Exocytosis
genes are not among the list of NRSF binding partners. In
addition, the fact that NRSF is not significantly differentiated in
brain tumors suggests that NRSF might not form a Type I circuit
with miR-9 in brain tumors.
Small dsRNAs can induce transcription activation [41–42],
which provides another perspective of the mRNA co-expression
with miRNA–miRNA-mediated activation. Three genes, E-
cadherin, P21, and VEGF, are induced by dsRNAs in the 59
promoter region in human cancer cell lines [42]. In cerebellar
development, VEGF is co-expressed with late-expressed miR-125,
whereas E-cadherin and P21 are either not significantly changed
or are co-expressed with late miR-9 and miR-22, respectively, in
another series (personal communication with J.M. Lee). In
addition, data from the RIKEN Brain Science Institute show that
E-cadherin is late-expressed in murine cerebellar development.
Interestingly, enrichment of miRNA core motifs are reported in
the 59 UTR compared with non-target motifs, and particularly the
enrichment of reverse complementary miRNA core motifs in the
59 UTR appears more frequently in the co-expressed genes of
miR-124 than that in 39 UTR [43], which raises a question as to
whether the miRNAs are likely to induce expression from the
59UTR. A survey of the 59 UTR patterns of the synaptic
transmission genes for 7-nt miRNA motifs shows that the
significant miRNAs shared between cerebellar development and
MB match various synaptic transmission genes. MiR-15 has the
greatest degree of multiplicity of 59 UTR matches with synaptic
transmission for reverse complementary seed sequences among the
significant late miRs. In Xenopus embryonic development, miR-
15 regulates Nodal signaling and acts at the crossroads of Nodal
signaling and WNT signaling [44]. Intriguingly, miR-15 is found
most significant for its targets non-coherence, especially for signal
transduction related functions in mouse development (Table S17)
while target gene acvr2 is coherent to miR-15 consistent with that
in [44].
Recently miRNA-target interactions have been approached in
terms of translational repression of the target proteins. Substan-
tial amount of miRNA inhibitions of translation are identified
[45–46]. Taking into account of this alternative mechanism of
miRNA regulation, the miRNA–mRNA co-expression might
represent a negative feedback response at the level of
translational repression. For example, Baek et al[45] has shown
there is a significant cohort of genes were depressed during the
protein synthesis with little or no change of mRNA expression
although the depression is relatively modest compared with many
other targets.
In this manuscript, we attempted to categorize the co-expressed
miRNA-target pairs with regard to their functions and temporal-
tissue specificity. Although the exact mechanism for the tissue and
process specific miRNA–mRNA co-expression observed in the
miRNA–mRNA Co-Expression
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processes that are likely part of the mechanism of interest.
Knowledge of the significant miRNAs and processes shared
between cerebellar development and MBs may facilitate target
selection for brain tumor therapy.
Materials and Methods
miRNA in situ chip data analysis
miRNAs profiled at P7 and P60 of postnatal mouse cerebellum
were hybridized on customized RAKE microarray chips with
approximately 1700 probes. Significant differences between
probes for the same miRNA from P7 to P60 were determined
using a Wilcoxon rank sum test and the logarithmic fold-changes
in expression were calculated. Fold-changes in relative expression
of miRNAs during lung development were obtained from
Williams et al.[24].
Prediction, mRNA data sets, coherent, and non-coherent
target sets
TargetScanS [28], PITA[29] and picTar[30] target predictions
are obtained from the respectively internet sites. There were 54
conserved miRNAs commonly present in the cerebellar develop-
ment miRNA data set and there were 59 conserved miRNAs
commonly present in the lung development miRNA data set.
Mouse development mRNA data sets and MB mRNA microarray
data are as described in Kho et al.[20]. Homologous genes were
identified between mouse microarray chip probes and the human
genome, resulting in 6790 homologous genes in the mouse
cerebellar development data series and 6356 homologous genes in
the mouse lung development data series. Coherent and non-
coherent target sets in each tissue during development were
calculated as described previously.
Significance test of miRNAs
Significance of the change in expression during development for
both the coherent target set and the non-coherent target set of
each miRNA were assessed using a Wilcoxon rank sum test against
the corresponding non-target control set of genes. For example,
the logarithmic fold-change of expression from P7 to P60 of the
non-coherent target set of a late-expressed miRNA was tested
against the late-expressed non-target genes, whereas the coherent
target set of an early-expressed miRNA was tested against the
early-expressed non-target genes.
GO (Gene Ontology), other functional terms, and
significant GO terms
Gene sets from GO, BBID (Biological Biochemical Image
Database), Biocarta, and Kegg pathways were obtained from
DAVID Bioinformatics Resource (http://david.abcc.ncifcrf.gov).
Each functional set was intersected with the coherent target set
and non-coherent target set of each miRNA and significant
coherent ontological target sets or non-coherent ontological
target sets were identified via a Wilcoxon rank sum test using
Matlab (MathWorks; http://www.mathworks.com) against the
corresponding non-target genes that had a positive-correlated
developmental profile to the target set. In order to correct for
multiple testing, we conducted Holms-Bonferroni adjustment
according to the smallest p-value for each GO term from the
Wilcoxon rank sum test (Table S18). In all three cases with
TargetScans, picTar and PITA target predictions, synaptic
transmission and related processes appear in the corrected top
GO term list.
Robustness of GO analysis
We tested the enrichment of the non-coherent ontological terms
for late miRNAs using sigPathway R package in the background of
non-target late genes in developing cerebellum. The ontological
terms are the above gene sets that intersect with gene sets of
developmentally non-coherent late miRNA targets. sigPathway is
an independent GO pathway analysis package [47]. Synaptic
transmission and other related ontological get sets again are found
significantly non-coherent to late miRNAs in developing cerebel-
lum. The same test of the ontological enrichment of non-coherent
miRNA targets in mouse Ptch+/2 MB samples and human MB
cell lines using sigPathway show a similar list of top pathways (Table
S19).
59UTR miR core motif match
The 59 UTR sequences were obtained from the database
developed by Mignone et al.[48]. miRNA core motifs (7nt) were
searched for in the 59 UTR of the genes involved in synaptic
transmission, exocytosis, and chromosome categories (Table S20, S21,
S22).
Validation in cerebellar development duplicate data set
All the significant target sets of miRNAs and GO terms were
tested/cross-tested in the two duplicate developmental cerebellum
mRNA expression series. There are in all 367 inconsistent genes
among 6790 genes in terms of correlation of the expressions and
135 inconsistent among 2633 target genes. There are no
inconsistent synaptic transmission genes. The correlations of the
gene expressions are included in Table S6. The genes predicted by
PITA and picTar for the GO processes in Table S6 are listed in
Table S23 and Table S24 respectively.
Supporting Information
Figure S1 Heat-map image of the logarithmic expression of
miRNAs in developing cerebellum P7 and P60.
Found at: doi:10.1371/journal.pone.0005436.s001 (1.17 MB TIF)
Table S1 miRNA expression data of developing murine lung.
Found at: doi:10.1371/journal.pone.0005436.s002 (0.07 MB
PDF)
Table S2 Significant miRNAs in developing cerebellum using
PITA prediction.
Found at: doi:10.1371/journal.pone.0005436.s003 (0.01 MB
PDF)
Table S3 Significant miRNAs in developing cerebellum using
picTar prediction.
Found at: doi:10.1371/journal.pone.0005436.s004 (0.01 MB
PDF)
Table S4 Significant miRNAs developing lung.
Found at: doi:10.1371/journal.pone.0005436.s005 (0.01 MB
PDF)
Table S5 Enriched non-coherent GO terms for late expressed
miRNAs in developing cerebellum compared with non-targets of
the same term.
Found at: doi:10.1371/journal.pone.0005436.s006 (0.01 MB
PDF)
Table S6 Enriched processes of non-coherent genes of miRNA
targets common in cerebellum development and Medulloblasto-
ma.
Found at: doi:10.1371/journal.pone.0005436.s007 (0.02 MB
PDF)
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cerebellum at days P10, P15, P21, and P30.
Found at: doi:10.1371/journal.pone.0005436.s008 (0.06 MB
XLS)
Table S8 Significant GO terms in developing cerebellum
comparing targets with non-target control set (PITA target
prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s009 (0.01 MB
PDF)
Table S9 Significant GO terms in developing cerebellum
comparing targets with non-target control set (picTar target
prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s010 (0.01 MB
PDF)
Table S10 Summary of the enriched GO terms of late-expressed
miRNA coherent/non-coherent targets in murine Ptch+/2 MB
and human MB cell line.
Found at: doi:10.1371/journal.pone.0005436.s011 (0.03 MB
PDF)
Table S11 The statistic significance and other qualifications of
the shared miRNA non-coherent GO terms between brain tumor
and development (picTar target prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s012 (0.01 MB
PDF)
Table S12 The statistic significance and other qualifications of
the shared miRNA non-coherent GO terms between brain tumor
and development (PITA target prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s013 (0.02 MB
XLS)
Table S13 miRNA expressions in cerebellum development and
rank change in NCI CNS tumors;
Found at: doi:10.1371/journal.pone.0005436.s014 (0.02 MB
XLS)
Table S14 Common Enriched GO terms in developing
Cerebellum and Lung.
Found at: doi:10.1371/journal.pone.0005436.s015 (0.02 MB
XLS)
Table S15 Significant miRNAs for their targets’ coherence or
non-coherence in developing murine lung (picTar prediction is
used).
Found at: doi:10.1371/journal.pone.0005436.s016 (0.01 MB
XLS)
Table S16 Common Enriched GO terms in developing
Cerebellum and Lung (picTar prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s017 (0.02 MB
XLS)
Table S17 Ranksum test of non-coherent targets of miR-15
against non targets in the same GO category.
Found at: doi:10.1371/journal.pone.0005436.s018 (0.44 MB
XLS)
Table S18 Holm correction for non-coherent Go terms in
developing cerebellum (including results from three predictions:
TargetScanS, PITA and picTar).
Found at: doi:10.1371/journal.pone.0005436.s019 (0.03 MB
XLS)
Table S19 List of Top Pathways of non-coherent targets of late
miRNAs in developing murine cerebellum, Ptch+/2 MB and
human MB cell line using sigPathway R package.
Found at: doi:10.1371/journal.pone.0005436.s020 (0.04 MB
XLS)
Table S20 59 UTR of Synaptic Transmission Genes that match
miRNAs.
Found at: doi:10.1371/journal.pone.0005436.s021 (0.15 MB
XLS)
Table S21 59 UTR of Exocytosis Genes that match miRNAs.
Found at: doi:10.1371/journal.pone.0005436.s022 (0.06 MB
XLS)
Table S22 59 UTR of Chromosome Genes that match miRNAs.
Found at: doi:10.1371/journal.pone.0005436.s023 (0.15 MB
XLS)
Table S23 Enriched processes of non-coherent genes of miRNA
targets common in cerebellum development and Medulloblastoma
(PITA prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s024 (0.05 MB
XLS)
Table S24 Enriched processes of non-coherent genes of miRNA
targets common in cerebellum development and Medulloblastoma
(picTar prediction is used).
Found at: doi:10.1371/journal.pone.0005436.s025 (0.03 MB
XLS)
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